Inamura N - Search Results

1

Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex.

Ohori M, Kinoshita T, Okubo M, Sato K, Yamazaki A, Arakawa H, Nishimura S, Inamura N, Nakajima H, Neya M, Miyake H, Fujii T. Ohori M, et al. Among authors: inamura n. Biochem Biophys Res Commun. 2005 Oct 14;336(1):357-63. doi: 10.1016/j.bbrc.2005.08.082. Biochem Biophys Res Commun. 2005. PMID: 16139248

2

Biochemical and pharmacological characterization of FK706, a novel elastase inhibitor.

Shinguh Y, Imai K, Yamazaki A, Inamura N, Shima I, Wakabayashi A, Higashi Y, Ono T. Shinguh Y, et al. Among authors: inamura n. Eur J Pharmacol. 1997 Oct 15;337(1):63-71. doi: 10.1016/s0014-2999(97)01284-3. Eur J Pharmacol. 1997. PMID: 9389382

3

Biochemical and pharmacological characterization of FR134043, a novel elastase inhibitor.

Shinguh Y, Yamazaki A, Inamura N, Fujie K, Okamoto M, Nakahara K, Notsu Y, Okuhara M, Ono T. Shinguh Y, et al. Among authors: inamura n. Eur J Pharmacol. 1998 Mar 26;345(3):299-308. doi: 10.1016/s0014-2999(98)00028-4. Eur J Pharmacol. 1998. PMID: 9592030

4

Histone deacetylase inhibitors from microorganisms: the Astellas experience.

Masuoka Y, Shindoh N, Inamura N. Masuoka Y, et al. Among authors: inamura n. Prog Drug Res. 2008;66:335, 337-59. doi: 10.1007/978-3-7643-8595-8_7. Prog Drug Res. 2008. PMID: 18416310 Review.

5

A new class of nonpeptide bradykinin B(2) receptor ligand, incorporating a 4-aminoquinoline framework. Identification of a key pharmacophore to determine species difference and agonist/antagonist profile.

Sawada Y, Kayakiri H, Abe Y, Mizutani T, Inamura N, Asano M, Aramori I, Hatori C, Oku T, Tanaka H. Sawada Y, et al. Among authors: inamura n. J Med Chem. 2004 May 6;47(10):2667-77. doi: 10.1021/jm030326t. J Med Chem. 2004. PMID: 15115408

6

A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 2. Overcoming the species difference between guinea pig and man.

Abe Y, Kayakiri H, Satoh S, Inoue T, Sawada Y, Inamura N, Asano M, Hatori C, Sawai H, Oku T, Tanaka H. Abe Y, et al. Among authors: inamura n. J Med Chem. 1998 Oct 8;41(21):4053-61. doi: 10.1021/jm980214f. J Med Chem. 1998. PMID: 9767642

7

Release of neutrophil elastase and its role in tissue injury in acute inflammation: effect of the elastase inhibitor, FR134043.

Fujie K, Shinguh Y, Inamura N, Yasumitsu R, Okamoto M, Okuhara M. Fujie K, et al. Among authors: inamura n. Eur J Pharmacol. 1999 Jun 11;374(1):117-25. doi: 10.1016/s0014-2999(99)00268-x. Eur J Pharmacol. 1999. PMID: 10422648

8

Effect of FR128998, a novel PAF receptor antagonist, on endotoxin-induced disseminated intravascular coagulation.

Yokota Y, Inamura N, Asano M, Yamamoto Y, Nakahara K, Notsu Y, Ono T, Watanabe M. Yokota Y, et al. Among authors: inamura n. Eur J Pharmacol. 1994 Jun 13;258(3):239-46. doi: 10.1016/0014-2999(94)90485-5. Eur J Pharmacol. 1994. PMID: 8088357

9

Pharmacological characterization of a novel, orally active, nonpeptide bradykinin B2 receptor antagonist, FR167344.

Inamura N, Asano M, Hatori C, Sawai H, Hirosumi J, Fujiwara T, Kayakiri H, Satoh S, Abe Y, Inoue T, Sawada Y, Oku T, Nakahara K. Inamura N, et al. Eur J Pharmacol. 1997 Aug 20;333(1):79-86. doi: 10.1016/s0014-2999(97)01100-x. Eur J Pharmacol. 1997. PMID: 9311664

10

A 5-lipoxygenase inhibitor, FR110302, suppresses airway hyperresponsiveness and lung eosinophilia induced by Sephadex particles in rats.

Asano M, Inamura N, Nakahara K, Nagayoshi A, Isono T, Hamada K, Oku T, Notsu Y, Kohsaka M, Ono T. Asano M, et al. Among authors: inamura n. Agents Actions. 1992 Jul;36(3-4):215-21. Agents Actions. 1992. PMID: 1382375

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters